Stay updated with breaking news from Diagnostic Cortex. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, today announced the pricing of its underwritten offering of 17,391,832 shares of its common stock at a price to...
Persistent, high double-digit growth in Lung Diagnostic test volume - growing 65% in FY2023 versus FY2022 - and the sixth consecutive quarter with greater than 50% year-over-year growth; Ongoing...
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the fourth quarter and year ended December 31, 2023...
Biodesix, Inc. , a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will present and host... | May 31, 2023
BOULDER, Colo.--(BUSINESS WIRE)--May 31, 2023--